A positive SPTBN2-FLI1 feedback axis promotes bladder cancer via PI3K/AKT activation
Cellular Signalling · 2026-07 · 143 · 112471
DOI: 10.1016/j.cellsig.2026.112471 ↗Kurz gefasst
Fachartikel in der Zeitschrift Cellular Signalling, 2026-07. Verfasst von Xiaoyan Guo und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Integrated Traditional Chinese and Western Medicine, The First Affiliated Hospital of Zhengzhou University, Zhengzhou 450000, Henan Pro…. Hauptthemen laut MEDLINE: Proto-Oncogene Proteins c-akt, Phosphatidylinositol 3-Kinases, Urinary Bladder Neoplasms, Proto-Oncogene Protein c-fli-1. Die Arbeit nennt 36 Literaturangaben. Gefördert von: Natural Science Foundation of Hubei Province, Natural Science Foundation of Hunan Province.
Abstract (Originalsprache)
Bladder cancer (BLCA) is characterized by high recurrence rates and limited treatment efficacy in advanced stages, prompting investigation into the role of SPTBN2 in BLCA pathogenesis and its potential as a prognostic biomarker and therapeutic target. Analysis of BLCA patient samples revealed significant SPTBN2 overexpression, which independently correlated with poor clinical outcomes. Functional assays demonstrated that SPTBN2 knockdown suppressed malignant phenotypes, including proliferation, migration, and colony formation in BLCA cell lines. Mechanistically, a reciprocal regulatory loop between SPTBN2 and the transcription factor FLI1 was identified, driving tumor progression through activation of the PI3K/AKT pathway and induction of epithelial-mesenchymal transition. Pharmacological inhibition of PI3K effectively counteracted the oncogenic effects mediated by SPTBN2 in both in vitro and in vivo models. These findings establish SPTBN2 as a novel oncoprotein and prognostic biomarker in BLCA, and highlight the SPTBN2-FLI1-PI3K/AKT axis as a promising therapeutic target for intervention.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Integrated Traditional Chinese and Western Medicine, The First Affiliated Hospital of Zhengzhou University, Zhengzhou 450000, Henan Province, China. Electronic address: guoxy@zzu.edu.cn.
- Department of Urology, Wuhan Central Hospital of Tongji Medical College, Huazhong University of Science and Technology, Wuhan 430014, Hubei Province, China. Electronic address: zhucx@zxhospital.com.
- Department of Urology, The Second Xiangya Hospital, Central South University, Changsha 410011, Hunan Province, China. Electronic address: yinzhuo@csu.edu.cn.
Förderung
- Natural Science Foundation of Hubei Province
- Natural Science Foundation of Hunan Province
Zitieren
APA
Guo, X., Zhu, C., & Yin, Z. (2026). A positive SPTBN2-FLI1 feedback axis promotes bladder cancer via PI3K/AKT activation. Cellular Signalling, 143, 112471. https://doi.org/10.1016/j.cellsig.2026.112471
Vancouver
Guo X, Zhu C, Yin Z. A positive SPTBN2-FLI1 feedback axis promotes bladder cancer via PI3K/AKT activation. Cellular Signalling. 2026;143:112471. doi:10.1016/j.cellsig.2026.112471
BibTeX
@article{Guo2026,
author = {Guo, Xiaoyan and Zhu, Chenxi and Yin, Zhuo},
title = {A positive SPTBN2-FLI1 feedback axis promotes bladder cancer via PI3K/AKT activation},
journal = {Cellular Signalling},
year = {2026},
volume = {143},
pages = {112471},
doi = {10.1016/j.cellsig.2026.112471}
}
EUVIMED